Description
A comprehensive 40 modules e-Course on the important aspects of critical care. The course will span for a duration of 120 days including “Performance Evaluation & Certification”
About ISCCM
Indian Society of Critical Care Medicine was established on 9th October, 1993, in Mumbai, India. It is the largest non-profit association of Indian Physicians, Nurses, Physiotherapists and other allied health care professionals involved in the care of the critically ill. ISCCM which was started with a small group of consultants, from Mumbai, is now having membership of 12046, comprising of 87 city branches all across the India with headquarter at Mumbai.
Topics
– Module 1: Airway
– Module 2: ABG – Arterial Blood Gas
– Module 3: Basic Mechanical Ventilation
– Module 4: Mechanical Ventilation – II
– Module 5: Noninvasive Ventilation
– Module 6: Weaning from Mechanical Ventilation
– Module 7: Basic Hemodynamic Monitoring
– Module 8: Advance Hemodynamic Monitoring
– Module 9: Oxygen Therapy
– Module 10: Radiology in ICU Part – I
– Module 11: Radiology in ICU Part – II
– Module 12: Ultrasound in ICU
* Module 13: Principles of Antibiotic Therapy
– Module 14: Sepsis
– Module 15: Antibiotic Stewardship
– Module 16: Nosocomial Infections
– Module 17: Fungal in ICU
– Module 18: Pulmonary Embolism
– Module 19: Congestive heart failure
– Module 20: Acute Coronary Syndrome
– Module 21: Hypertensive Emergencies
– Module 22: Electrolytes: Hypokalemia & Hyperkalemia
– Module 23: Hyponatremia
– Module 24: Echocardiography
– Module 25: Nutritional Support
– Module 26: Glycemic Control in ICU
– Module 27: Head and Spinal Injuries
– Module 28: CVA Acute Stroke
– Module 29: Transfusion Practices in ICU
– Module 30: Infection Control
– Module 31: GI Bleed
– Module 32: Severe Acute Pancreatitis
– Module 33: Liver Failure
– Module 34: Acute Kideny Injury
– Module 35: Poisioning
– Module 36: Obstetric emergencies
– Module 37: Oncological Emergencies
– Module 38: Pediatric Emergencies
– Module 39: Brain Death
– Module 40: End of life care issues in critically ill patents
